Publication:
A potent drug candidature of Cu(II) pyrazino[2,3‐f][1,10]phenanthroline complexes with bioactive ligands: synthesis, crystal structures, biomolecular interactions, radical scavenging and cytotoxicities

dc.contributor.authorİnci, Duygu
dc.contributor.authorZorlu, Yunus
dc.contributor.buuauthorAydın, Rahmiye
dc.contributor.buuauthorVatan, Özgür
dc.contributor.departmentFen Edebiyat Fakültesi
dc.contributor.departmentFen Edebiyat Fakültesi
dc.contributor.departmentKimya Bölümü
dc.contributor.departmentBiyoloji Bölümü
dc.contributor.orcid0000-0002-7687-3284
dc.contributor.orcid0000-0003-4944-0181
dc.contributor.researcheridO-7508-2015
dc.contributor.researcheridAAH-8936-2021
dc.contributor.scopusid56261495600
dc.contributor.scopusid16235098100
dc.date.accessioned2024-01-17T06:15:24Z
dc.date.available2024-01-17T06:15:24Z
dc.date.issued2020-08-01
dc.description.abstractA novel ternary copper(II) complexes, - [Cu(py-phen)(asn)(NO3)(H2O)] (1) and [Cu(py-phen)(trp)(H2O)]NO3(2)- (py-phen: pyrazino[2,3-f][1,10]phenanthroline, asn: asparagine, trp: tryptophan), have been synthesized and characterized by CHN analysis, ESI-MS, FTIR and single-crystal X-ray diffraction techniques. Interaction of the complexes1and2with CT-DNA has been investigated by absorption spectral titration, EB and Hoechst 33258 displacement assay. The interaction between the complexes1and2and BSA was investigated by electronic absorption and fluorescence spectroscopy methods. The experimental outcomes indicate that the fluorescence quenching mechanism between the complexes1and2and BSA is a static quenching process. The Stern-Volmer constants, binding constants, binding sites and the corresponding thermodynamic parameters (Delta G, Delta H, Delta S) of BSA + complex systems were determined at different temperatures. The binding distance between the complexes1and2and BSA was calculated according to FRET. The effect of the complexes1and2on the conformation of BSA was also examined using synchronous, two dimensional (2D) and three dimensional (3D) fluorescence spectroscopy. Radical scavenging activity of the complex was determined in terms of EC50, using the DPPH and H(2)O(2)method. The anticancer activities of the complexes1and2were investigated using an XTT assay against three cancer cell lines (MCF-7, Caco-2 and A549) and non-tumor cell line (BEAS-2B). A potent drug candidature of two new copper(II) complexes, - [Cu(py-phen)(asn)(NO3)(H2O)] (1) and [Cu(py-phen)(trp)(H2O)]NO3(2)- (py-phen: pyrazino[2,3-f][1,10]phenanthroline, asn: asparagine, trp: tryptophan), have been synthesized and characterized by CHN analysis, FTIR, ESI-MS and single-crystal X-ray diffraction techniques. The complexes have been tested for theirin vitrobiomolecular interactions by the spectroscopic methods. Furthermore, radical scavenging and anticancer activities of the complexes was also investigated.
dc.identifier.citationİnci, D. vd. (2021). "A potent drug candidature of Cu(II) pyrazino[2,3‐f][1,10]phenanthroline complexes with bioactive ligands: Synthesis, crystal structures, biomolecular interactions, radical scavenging and cytotoxicities". Journal of Biomolecular Structure and Dynamics, 39(18), 7194-7212.
dc.identifier.doihttps://doi.org/10.1080/07391102.2020.1808070
dc.identifier.eissn1538-0254
dc.identifier.endpage7212
dc.identifier.issn0739-1102
dc.identifier.issue18
dc.identifier.pubmed32811370
dc.identifier.scopus2-s2.0-85089592340
dc.identifier.startpage7194
dc.identifier.urihttps://www.tandfonline.com/doi/pdf/10.1080/07391102.2020.1808070
dc.identifier.urihttps://hdl.handle.net/11452/39080
dc.identifier.volume39
dc.identifier.wos000560478200001
dc.indexed.wosSCIE
dc.language.isoen
dc.publisherTaylor and Francis
dc.relation.bap(BİYGP-2018/1)
dc.relation.collaborationYurt içi
dc.relation.journalJournal of Biomolecular Structure and Dynamics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.subjectBiochemistry & molecular biology
dc.subjectBiophysics
dc.subjectAmino acids
dc.subjectAnticancer activity
dc.subjectBiomolecular interactions
dc.subjectCu(II)
dc.subjectPyrazino[2,3‐f][1,10]phenanthroline
dc.subjectRadical scavenging activity
dc.subjectBovine serum-albumin
dc.subjectDNA-binding
dc.subjectCopper(II) complex
dc.subjectEthidium-bromide
dc.subjectMetal-complexes
dc.subjectRuthenium(II)
dc.subjectFluorescence
dc.subjectAntioxidant
dc.subjectDNA/BSA
dc.subjectOxygen
dc.subject.emtreeAntineoplastic agent
dc.subject.emtreeAntineoplastic agent
dc.subject.emtreeBovine serum albumin
dc.subject.emtreeUnclassified drug
dc.subject.emtreeCopper pyrazino[2,3 f][1,10]phenanthroline complex
dc.subject.emtreeCisplatin
dc.subject.emtreeCoordination compound
dc.subject.emtreeCopper
dc.subject.emtreeDrug
dc.subject.emtreeHydrogen peroxide
dc.subject.emtreeLigand
dc.subject.emtreePhenanthroline derivative
dc.subject.emtreeA-549 cell line
dc.subject.emtreeMolecular interaction
dc.subject.emtreeIC50
dc.subject.emtreeMCF-7 cell line
dc.subject.emtreeHydrogen peroxide scavenging assay
dc.subject.emtreeHuman
dc.subject.emtreeHuman cell
dc.subject.emtreeFree radical scavenging assay
dc.subject.emtreeFluorescence resonance energy transfer
dc.subject.emtreeEC50
dc.subject.emtreeElectrospray mass spectrometry
dc.subject.emtreeArticle
dc.subject.emtreeSpectrofluorometry
dc.subject.emtreeXTT assay
dc.subject.emtreeX ray diffraction
dc.subject.emtreeThermodynamics
dc.subject.emtreeDrug conformation
dc.subject.emtreeDrug effect
dc.subject.emtreeDPPH radical scavenging assay
dc.subject.emtreeCytotoxicity
dc.subject.emtreeCrystal structure
dc.subject.emtreeDrug efficacy
dc.subject.emtreeBEAS-2B cell line
dc.subject.emtreeDrug mechanism
dc.subject.emtreeDrug response
dc.subject.emtreeDrug structure
dc.subject.emtreeDrug synthesis
dc.subject.emtreeBinding site
dc.subject.emtreeCaco-2 cell line
dc.subject.emtreeClinical effectiveness
dc.subject.emtreeComplex formation
dc.subject.emtreeControlled study
dc.subject.meshAntineoplastic agents
dc.subject.meshCaco-2 cells
dc.subject.meshCoordination complexes
dc.subject.meshCopper
dc.subject.meshHumans
dc.subject.meshHydrogen peroxide
dc.subject.meshLigands
dc.subject.meshPharmaceutical preparations
dc.subject.meshPhenanthrolines
dc.subject.meshSerum albumin
dc.subject.meshBovine
dc.subject.scopusComplex; Viscometry; Schiff Bases
dc.subject.wosBiochemistry & molecular biology
dc.subject.wosBiophysics
dc.titleA potent drug candidature of Cu(II) pyrazino[2,3‐f][1,10]phenanthroline complexes with bioactive ligands: synthesis, crystal structures, biomolecular interactions, radical scavenging and cytotoxicities
dc.typeArticle
dc.wos.quartileQ2 (Biochemistry & molecular biology)
dc.wos.quartileQ1 (Biophysics)
dspace.entity.typePublication
local.contributor.departmentFen Edebiyat Fakültesi/Kimya Bölümü
local.contributor.departmentFen Edebiyat Fakültesi/Biyoloji Bölümü
local.indexed.atPubMed
local.indexed.atScopus

Files

License bundle

Now showing 1 - 1 of 1
Placeholder
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: